Use of Somatostatin Analogs in Patients With Neuroendocrine Tumors

May 13, 2016
Wouter W. de Herder, MD, PhD

Wouter W. de Herder, MD, PhD, professor of Endocrine Oncology, Erasmus MC, discusses the use of somatostatin analogs in patients with neuroendocrine tumors, as well as significant clinical trials investigating these agents.